盐酸氨溴索联合盐酸丙卡特罗治疗小儿肺炎的效果分析

目的 研究盐酸氨溴索加盐酸丙卡特罗治疗小儿肺炎的临床效果。方法 选取2016年10月~2017年12月我院收治的小儿肺炎患者88例，随机分为研究组与对照组，每组44例。对照组给予常规治疗，研究组在对照组基础上予以口服盐酸氨溴索加盐酸丙卡特罗，对比两组患儿症状体征（喘息、咳嗽、咳痰、发热、肺部啰音）消退时间和临床疗效。结果 研究组喘息、咳嗽、咳痰、发热、肺部啰音消退时间分别为（2.66±1.08）d、（5.24±1.98）d、（3.68±1.44）d、（1.33±0.57）d、（4.53±2.14）d，均短于对照组的（4.22±2.34）d、（7.55±2.33）d、（5.43±2.50）d、（2.20±0.75）、（6.12±2.98）d，差异具有统计学意义（P＜0.05）。研究组治疗总有效率高于对照组（95.45% vs 79.55%），差异具有统计学意义（P＜0.05）。结论 盐酸氨溴索联合盐酸丙卡特罗治疗小儿肺炎，可有效改善其临床症状，提升治疗有效率。

Effect Analysis of Ambroxol Hydrochloride Combined with Procaterol Hydrochloride in the Treatment of Infantile Pneumonia

Objective To study the clinical effect of ambroxol hydrochloride and procaterol hydrochloride in the treatment of infantile pneumonia. Methods 88 patients with infantile pneumonia admitted to our hospital from October 2016 to December 2017 were randomly divided into study group and control group, with 44 cases in each group. The control group received routine treatment. The study group received oral ambroxol hydrochloride plus procaterol hydrochloride on the basis of the control group, and compared the symptoms and signs (wheeze, cough, cough, fever, lung snoring) of the two groups clinical efficacy. Results In the study group, wheezing, cough, cough, fever, and lung arpake regression time were (2.66±1.08)d, (5.24±1.98)d, (3.68±1.44)d, (1.33±0.57)d, (4.53±2.14)d, both shorter than the control group (4.22±2.34)d, (7.55±2.33)d，(5.43±2.50)d，(2.20±0.75)，(6.12±2.98)d，the difference was statistically significant (P<0.05). The total effective rate of the study group was higher than that of the control group (95.45% vs 79.55%)，the difference was statistically significant (P<0.05). Conclusion Ambroxol hydrochloride combined with procaterol hydrochloride in the treatment of infantile pneumonia can effectively improve its clinical symptoms and improve the efficiency of treatment.